New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
07:05 EDTALIMAlimera Sciences and STA sign deal to distribute ILUVIEN in Oceania
Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia, or STA, and Alimera Sciences. The exclusive agreement enables STA to distribute ILUVIEN, a sustained release intravitreal implant used to treat vision impairment associated with chronic diabetic macular oedema, when the condition is deemed insufficiently responsive to current available therapies.
News For ALIM From The Last 14 Days
Check below for free stories on ALIM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
09:15 EDTALIMAlimera Sciences likely to gain NDA approval for Illuvien, says Northland
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use